This Biotech's Guidance Seemingly Beat Expectations — But A Twist Slammed The Stock
Full-Year Revenue Guidance and Strong Quarter Drove Twist Bioscience Corporation (TWST) Higher in Q3
Twist Bioscience 2027 Outlook Signals Sharp Slowdown in AI Drug Discovery Growth
Twist Bioscience Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results
Loading...